|
2021
|
Invention
|
Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl[-benzamide.
The... |
|
2017
|
Invention
|
1f agonists. The present invention provides new pseudo-polymorphs of the hemisuccinate salt of 2,... |
|
|
Invention
|
Hydrates of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuc... |
|
|
Invention
|
Compositions and methods related to pyridinoylpiperidine 5-ht1f agonists. The present invention p... |
|
2016
|
G/S
|
Pharmaceutical preparations for human use for the treatment of central nervous system disorders, ... |
|
2011
|
Invention
|
Compositions and methods of synthesis of pyridinolypiperidine 5-ht1f agonists. The present invent... |
|
|
Invention
|
Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists. The present invent... |
|
|
Invention
|
Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents.
Carbam... |
|
2010
|
Invention
|
Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide. The ... |
|
|
Invention
|
Composition of 2,4,6- trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide.
Th... |
|
|
Invention
|
Compositions of cholinesterase inhibitors.
The present invention is directed to compositions, me... |
|
|
Invention
|
Compositions of cholinesterase inhibitors. The present invention is directed to compositions, met... |
|
2009
|
Invention
|
Stigmine conjugates for substance use disorders.
The invention relates to methods for the treatm... |
|
|
Invention
|
Stigmine conjugates for substance use disorders. The invention relates to methods for the treatme... |
|
2008
|
Invention
|
Methods for promoting wakefulness.
The present invention relates to methods of promoting wakeful... |
|
|
Invention
|
Methods for promoting wakefulness. The present invention relates to methods of promoting wakefuln... |
|
|
Invention
|
Compounds that inhibit cholinesterase. Compounds that inhibit cholinesterase activity and, upon h... |
|
2004
|
Invention
|
Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents. Carbamo... |
